Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAn updated site revision tag is visible (Revision: v3.4.2), and the previous funding notice and earlier revision tag (v3.4.1) have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check30 days agoChange DetectedAdded a government funding lapse notice and updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check37 days agoChange DetectedGlossary is now shown on the page. Metadata updates include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision tag 'Revision: v3.4.0'.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision history updated: added Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.1%

- Check73 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check94 days agoChange DetectedMinor update to the study page indicating a revision from v3.3.1 to v3.3.2; no substantive changes to study design, inclusion criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.